Last reviewed · How we verify
NCT05219214: CERTAIN
China Rheumatoid Arthritis Registry of Patients With Chinese Medicine
trial testing Chinese medicine in Rheumatoid Arthritis in 12,000 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 12,000 |
| Start date | 1 September 2019 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Chinese medicine
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Who can join
18 and older, any sex, with Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A multi-center registration study of clinical characteristics of rheumatoid arthritis (RA) patients with Chinese medicine.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): Rationale, design, and baseline characteristics of the first 11,764 enrollees.
Gong X, Liu WX, Li D, Peng QW, et al · · 2022 · cited 9× · PMID 35797864 · DOI 10.1016/j.phymed.2022.154236 -
Glucocorticoid Discontinuation in Patients with Rheumatoid Arthritis under Background of Chinese Medicine: Challenges and Potentials Coexist.
Yao CH, Zhang C, Song MG, Xia CM, et al · · 2025 · cited 1× · PMID 40553362 · DOI 10.1007/s11655-025-4212-3 -
Effectiveness and Safety of Biqi Capsules in 2,267 Patients with Rheumatoid Arthritis: A Real-World Clinical Study.
Ma XL, Xia CM, Chang T, Liu ZX, et al · · 2026 · PMID 41540164 · DOI 10.1007/s11655-026-4137-5
Verify or expand the search:
- PubMed search for NCT05219214
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Chinese medicine
Trials testing the same drug.
- NCT06467942 — Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection · NA · recruiting
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Guang'anmen Hospital of China Academy of Chinese Medical Sciences trials
Trials by the same sponsor.
- NCT07324148 — Acupuncture for Erectile Dysfunction · NA · not yet recruiting
- NCT07183813 — Acupuncture for Anxiety/Depression in Patients With Breast Cancer · NA · not yet recruiting
- NCT07150234 — Effectiveness of Acupuncture for Cervical Spondylotic Radiculopathy · NA · not yet recruiting
- NCT06996210 — Effect of Acupuncture on Chronic Nonspecific Neck Pain and Insomnia · NA · not yet recruiting
- NCT07079072 — Acupuncture for Lung Cancer-Related Fatigue · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05219214 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Last refreshed: 15 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05219214.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing